Amylyx Pharmaceuticals, Inc. AMLX Geographic — Operating Loss Carryforwards Expiration Period

Similar metrics at other companies

ASSTOperating loss carryforwards, subject to expiration

$94.1M+141%

TTMIVarious States — Operating Loss Carryforwards Expiration Year

511.30.0%

ADTNOperating Loss Carryforwards Expiration Year

5100.0%

REXOperating Loss Carryorwards Expiration Year

511.8—

HONOperating loss carryforward, not subject to expiration

$3.23B+3.8%

MAZEMA — Tax Credit Carryforward Expiration End Year

509.5—

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s geographic — operating loss carryforwards expiration period?

Amylyx Pharmaceuticals, Inc. (AMLX) reported geographic — operating loss carryforwards expiration period of 510 in Q4 2025.

How has Amylyx Pharmaceuticals, Inc.'s geographic — operating loss carryforwards expiration period changed year-over-year?

Amylyx Pharmaceuticals, Inc.'s geographic — operating loss carryforwards expiration period decreased by 0.0% year-over-year, from 510 to 510.

What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s geographic — operating loss carryforwards expiration period?

Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s geographic — operating loss carryforwards expiration period has grown at a 0.1% compound annual growth rate (CAGR), from 2K to 2K.

What does geographic — operating loss carryforwards expiration period mean?

This metric quantifies the remaining duration or time horizon during which the segment's accumulated operating loss carryforwards can be utilized to reduce future tax liabilities. A longer expiration period provides greater flexibility for the company to utilize these tax assets as the business scales and reaches profitability. It serves as a critical indicator of the longevity and utility of the segment's tax-related financial assets.